PTH and osteoporosis: Systemic PTH is the only osteoforming agent approved for the treatment of severe osteoporosis in men; it stimulates osteoblastic activity by increasing bone formation, increases trabecular and cortical thickness, and reduces fracture risk [3,11,12,13,14,15,16].